Biogen banks on government coverage to restart stalled Alzheimer's drug sales
Go back to Biogen banks on government coverage to restart stalled Alzheimer's drug sales| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 199.96 +5.72 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $194.24 | 52 Week High | $333.65 | |||
| Open | $195.49 | 52 Week Low | $223.02 | |||
| Day High | $201.18 | P/E | 25.60 | |||
| Day Low | $194.24 | EPS | $7.81 | |||
| Volume | 909,619 | |||||

